Viloxazine (trade name Qelbree) is a new non-stimulant ADHD medication. It’s an anti-depressant, like atomoxetine (Straterra), which it will probably replace because it is more effective (it affects more neurotransmitters) and has a lower frequency of side effects. That’s...
Viloxazine (trade name Qelbree) is a new non-stimulant ADHD medication. It’s an anti-depressant, like atomoxetine (Straterra), which it will probably replace because it is more effective (it affects more neurotransmitters) and has a lower frequency of side effects. That’s all good. It may even replace some of the stimulants, which are the most effective meds, but aren’t the best for some people for various reasons. It’s presumably non-addictive and nonabusable. It may be a great resource in this time of shortage of the stimulants.
Now for the bad news; it seems to currently cost about $10 a pill.
My Comment O the Day:
The article announcing this was a little biased, over emphasizing the possible side effects of stimulants. While I know there have been problems, I have never personally seen one. The non-stimulants also have their own problems. However, this new medication appears very promising.
Question O the Day:
If I did all the things I’m supposed to do for my health, would I have time to do anything else?
(and would I have to eat Brussel sprouts, kale, and broccoli?)
doug
#ADHD #adultADHD
ADHDMEds
